Similarly, the high expression of cyclin T1 correlated with an improved disease-free survival of patients with stomach adenocarcinoma [37] and high CDK9 expression was associated with prolonged survival in breast cancer [34]. This evidence concerns the gene CDK9 and breast carcinoma.